The Evidence

Is there hope? What "managed, not cured" means

Yes, there is real hope. MCS can improve, remission and regained function occur, and some people regain meaningful tolerance. But no treatment has been shown to reliably cure consensus-defined MCS or permanently restore normal chemical tolerance across the population. “Managed, not cured” rejects both false promises and hopelessness.

“Managed, not cured” is not a sentence of hopelessness. It is a promise to tell the truth: there is no established cure, but meaningful improvement, remission, regained function, and increased tolerance can occur.

The words can sound harsher than we mean them

If you have just learned that you may have Multiple Chemical Sensitivity, the phrase “managed, not cured” can sound like a door closing. It is not meant that way.

It means something precise: there is presently no treatment shown to reliably eliminate MCS and permanently restore normal chemical tolerance in people meeting the established consensus criteria. It does not mean you cannot improve. It does not mean your present level of disability is your permanent future. It does not mean science has proven that the underlying changes cannot reverse.

We use the phrase because people with MCS deserve both hope and honesty. False promises are not hope. Neither is telling someone that nothing can ever change.

What we know

The clinical course of MCS is variable. Long-term and population studies, imperfect as they are, contain people who remained highly symptomatic, people who improved, and people who described remission. A five-year Japanese chemical-intolerance follow-up found substantial self-reported improvement among many respondents. A much smaller nine-year Iowa follow-up also found improvement in most participants, although only a small number met that study’s strict definition of remission and many remained symptomatic.

We do not need a five-person exposure experiment to justify hope. Longitudinal studies and patient histories already show that chemical intolerance can improve in some people over time. Hope rests on documented variation in outcome—not on converting a tiny uncontrolled case series into treatment evidence.

What hope should look like

Hope with MCS should be concrete. It may mean finding housing where the body is not repeatedly pushed into reactions. It may mean learning which exposures are most important rather than trying to control every molecule. It may mean restoring sleep, nutrition, movement, social connection, and medical care that were lost when the illness took over daily life.

For another person, hope may mean gradually tolerating more environments. For someone else it may mean returning to work, driving again, attending church, visiting family, or walking into a store without needing days to recover. For the most severely affected person, the first victory may simply be creating a stable environment in which the body has a chance to stop being repeatedly provoked.

Those outcomes matter even if they do not meet the scientific definition of cure.

The mind can help without being blamed

MCS is psychologically difficult because the threat is often invisible and unpredictable. A person can be fine in one place and suddenly become sick in another. Other people may smell nothing or feel nothing. Plans can collapse because of a cleaning product, a renovation, exhaust, fragrance, smoke, or a new material.

Fear, grief, anger, hypervigilance, depression, and isolation can follow. Treating those consequences is not an admission that the illness is psychological. Calming an overactivated nervous system, reducing fear, improving sleep, and rebuilding confidence can all be legitimate parts of living better with a physical illness.

But we keep the outcomes straight. Better coping is better coping. Lower fear is lower fear. Improved sleep is improved sleep. Restored chemical tolerance is restored chemical tolerance. One should never be substituted for another.

Why we will not promise a cure

People with poorly understood chronic illnesses are especially vulnerable to absolute claims: detox programs, supplements, devices, diets, nervous-system programs, or practitioners promising that the one missing answer has finally been found.

Some interventions may genuinely help specific people. That does not justify promoting them as a proven cure for the consensus-defined MCS population. Published controlled evidence has not shown brain retraining to reverse MCS or reliably restore chemical tolerance. Likewise, promising biological mechanisms such as TRPA1/TRPV1, mast-cell signaling, oxidative stress, autonomic dysfunction, and immune changes have not yet yielded a universally established treatment.

The honest position is therefore not passive. It is an invitation to do better research.

What the registry is answering

One of the Canary Registry’s central jobs is to find the people who improved and study them as carefully as the people who remain severely ill. What changed first? Which tolerances returned? How durable was the improvement? What happened immediately before improvement? What happened before relapse?

We also need to identify apparent “responders” to very different approaches and determine whether they were improving in the same way. Someone who becomes less afraid of fragrance is not necessarily the same as someone who can now tolerate fragrance without becoming ill. Someone who moves out of a contaminated building while beginning a retraining program has two major variables, not one.

Good recovery research does not take hope away from testimonials. It gives them enough structure to become useful evidence.

Where we stand

MCS is real, not imagined. It is managed, not cured.

“Managed, not cured” means there is presently no treatment shown to reliably eliminate MCS and permanently restore normal chemical tolerance. It does not mean that substantial improvement, remission, regained function, or increased tolerance cannot occur.

Our goal is not to teach people how to build a smaller and smaller life around MCS. Our goal is to help people become safer and more stable now while science learns why some bodies regain tolerance and how that recovery can be made more common.

That is real hope: not pretending we already have the cure, and not accepting that the present is necessarily permanent.

Sources and notes

These references support the specific claims discussed above. Study populations and limitations are described in the article; inclusion here does not mean every study used the 1999 consensus case definition.

Multiple Chemical Sensitivity: a 1999 consensus. Arch Environ Health. 1999;54(3):147-149. PMID: 10444033.

Azuma K et al. Factors affecting self-reported chemical intolerance: A five-year follow-up study in Japan. J Psychosom Res. 2019. PMID: 30782347.

Black DW, Okiishi C, Schlosser S. A nine-year follow-up of people diagnosed with multiple chemical sensitivities. Psychosomatics. 2000;41(3):253-261. PMID: 10849458.

Hauge CR et al. Mindfulness-based cognitive therapy (MBCT) for multiple chemical sensitivity: a randomized controlled trial. J Psychosom Res. 2015. PMID: 26311155.

We followed the evidence. Here’s where it leads →

Sources

Sources

1See the Position Paper evidence base and the pages linked from this one: Does avoiding chemicals help? · Can brain retraining cure MCS? · Can people recover from MCS?
2Black DW, Okiishi C, Schlosser S. The Iowa follow-up of chemically sensitive persons. Annals of the New York Academy of Sciences. 2001;933:48-56.
3Perales RB, Palmer RF, Rincon R, Viramontes JN, Walker T, Jaén CR, Miller CS. Does improving indoor air quality lessen symptoms associated with chemical intolerance? Primary Health Care Research & Development. 2022;23:e3. PMID: 35019834. DOI: 10.1017/S1463423621000864.
4Gibson PR, Elms AN, Ruding LA. Perceived treatment efficacy for conventional and alternative therapies reported by persons with multiple chemical sensitivity. Environmental Health Perspectives. 2003;111(12):1498–1504. PMID: 12948890.
← Back to MCSDisability.com
↑